MCIM
NEO icon

Meadow Creek Investment Management’s NeoGenomics NEO Stock Holding History

Meadow Creek Investment Management’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$236K Buy
12,342
+1,958
+19% +$45.9K ﹤0.01% 978
2019
Q2 		$228K Hold
10,384
– – ﹤0.01% 1000
2019
Q1 		$213K Buy
+10,384
New +$180K ﹤0.01% 995

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.95B AUM 49.89% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Meadow Creek Investment Management's NEO Position: Q3 2019 in Review

Meadow Creek Investment Management increased its NeoGenomics (NEO) stake by 19% in Q3 2019, buying an estimated $45.9K and bringing the position to 12,342 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #978.

Meadow Creek Investment Management first reported a position in NEO in Q1 2019 and has held it in 3 quarters since. 253 funds tracked by Wall St. Rank hold NEO as of Q3 2019.

  • Meadow Creek Investment Management held 12,342 shares of NeoGenomics worth $236K as of Q3 2019.
  • Meadow Creek Investment Management bought 1,958 NeoGenomics shares in Q3 2019, an estimated $45.9K.
  • NeoGenomics made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #978 holding.
  • Meadow Creek Investment Management first reported a position in NeoGenomics in Q1 2019 and has held it in 3 quarters since.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.